Dr. Kaveh Hoda

There's a lot of concern over that, obviously. But even in the medical world outside of the academic centers, I know a lot of doctors right now are concerned. And they're concerned about what's going to happen to the state of our scientific community that helps us with new advancements in medical technology in the coming years. And it seems like, as Venkatesh was alluding to,

We're dismantling all our ability to follow, to study, to really closely track infectious disease in a time that is exceedingly dangerous across the world with rising disease, tuberculosis in this country, measles in this country. In Uganda, there's Ebola again. There's threats all over the world, and this is one of the worst times I could think of to be in this moment of austerity.

We're dismantling all our ability to follow, to study, to really closely track infectious disease in a time that is exceedingly dangerous across the world with rising disease, tuberculosis in this country, measles in this country. In Uganda, there's Ebola again. There's threats all over the world, and this is one of the worst times I could think of to be in this moment of austerity.

We're dismantling all our ability to follow, to study, to really closely track infectious disease in a time that is exceedingly dangerous across the world with rising disease, tuberculosis in this country, measles in this country. In Uganda, there's Ebola again. There's threats all over the world, and this is one of the worst times I could think of to be in this moment of austerity.

And particularly because so much of it seems unclear to us why. Why these things are being done. Is it all because of this ridiculous gender ideology? Do they actually think they're saving money with some of these things? It's a very unclear time. And of course, there are a lot of

And particularly because so much of it seems unclear to us why. Why these things are being done. Is it all because of this ridiculous gender ideology? Do they actually think they're saving money with some of these things? It's a very unclear time. And of course, there are a lot of

And particularly because so much of it seems unclear to us why. Why these things are being done. Is it all because of this ridiculous gender ideology? Do they actually think they're saving money with some of these things? It's a very unclear time. And of course, there are a lot of

People in the medical world, doctors included, that are conservative or Republican voters, getting into conversations with them about this is sort of a tough thing to do. Because, like Venkatesh mentioned, they, like a lot of us, want to make sure we're doing this in a cost-effective manner.

People in the medical world, doctors included, that are conservative or Republican voters, getting into conversations with them about this is sort of a tough thing to do. Because, like Venkatesh mentioned, they, like a lot of us, want to make sure we're doing this in a cost-effective manner.

People in the medical world, doctors included, that are conservative or Republican voters, getting into conversations with them about this is sort of a tough thing to do. Because, like Venkatesh mentioned, they, like a lot of us, want to make sure we're doing this in a cost-effective manner.

Something we talk about and we have been talking about in medicine for a long time, particularly academic medicine, interestingly enough. which is really on the cutting board. It's academic medicine that usually talks about, you know, trying to be cost-effective. What tests are we going to order? What labs do we need to get? How are we doing this in the most cost-effective way?

Something we talk about and we have been talking about in medicine for a long time, particularly academic medicine, interestingly enough. which is really on the cutting board. It's academic medicine that usually talks about, you know, trying to be cost-effective. What tests are we going to order? What labs do we need to get? How are we doing this in the most cost-effective way?

Something we talk about and we have been talking about in medicine for a long time, particularly academic medicine, interestingly enough. which is really on the cutting board. It's academic medicine that usually talks about, you know, trying to be cost-effective. What tests are we going to order? What labs do we need to get? How are we doing this in the most cost-effective way?

These are important things that are discussed. And across the political spectrum in medicine, I think there is some concern, even amongst some of the more right-leaning doctors. But again, it's hard because they've gone this far down the road. It's hard to know, you know, when they're going to pull back. What's the line in the sand for them about what is maybe too far for this administration?

These are important things that are discussed. And across the political spectrum in medicine, I think there is some concern, even amongst some of the more right-leaning doctors. But again, it's hard because they've gone this far down the road. It's hard to know, you know, when they're going to pull back. What's the line in the sand for them about what is maybe too far for this administration?

These are important things that are discussed. And across the political spectrum in medicine, I think there is some concern, even amongst some of the more right-leaning doctors. But again, it's hard because they've gone this far down the road. It's hard to know, you know, when they're going to pull back. What's the line in the sand for them about what is maybe too far for this administration?

Right.

Right.

Right.

Yeah, that's right. I mean, even here in the San Francisco Bay Area, you know, I've seen more vaccine hesitation than I remember ever seeing before in the past.